Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
Micafungin is an echinocandin antifungal agent available for clinical use in Japan, Europe, and the United States. Through inhibition of β-1,3-glucan production, an essential component of the fungal cell wall, micafungin exhibits potent antifungal activity against key pathogenic fungi, including Can...
Main Authors: | Wiederhold, Nathan P, Cota, Jason M, Frei, Christopher R |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2009
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108724/ |
Similar Items
-
Pharmacokinetics of micafungin in adult patients with invasive candidiasis and candidaemia
by: Kuse, ER, et al.
Published: (2008) -
Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
by: Glöckner, A
Published: (2011) -
A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
by: Kohno, S., et al.
Published: (2012) -
Impact of early catheter removal during treatment of invasive candidiasis: analysis from two phase 3 micafungin trials
by: Nucci, M, et al.
Published: (2009) -
Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs - review of the literature
by: Wilke, MH
Published: (2011)